• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米多君。治疗特发性直立性低血压和夏伊-德雷格综合征的一种新药。

Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.

作者信息

Schirger A, Sheps S G, Thomas J E, Fealey R D

出版信息

Mayo Clin Proc. 1981 Jul;56(7):429-33.

PMID:6166817
Abstract

Five patients with idiopathic orthostatic hypotension, two of whom had central nervous system manifestations (Shy-Drager syndrome), were treated with midodrine, an investigational alpha-adrenergic agonist, in a dosage of 2.5 to 5 mg three times daily. Significant improvement was observed in the standing systolic and diastolic blood pressures at the end of 1 week of therapy in all patients and has been maintained for 10 to 15 months in all patients. No symptomatic side effects were noted. Supine systolic hypertension occurred in two patients and was treated with small doses of metoprolol.

摘要

五名特发性直立性低血压患者,其中两名有中枢神经系统表现(Shy-Drager综合征),接受了米多君治疗,米多君是一种正在研究的α-肾上腺素能激动剂,剂量为每日三次,每次2.5至5毫克。所有患者在治疗1周结束时,站立位收缩压和舒张压均有显著改善,且在所有患者中已维持10至15个月。未观察到有症状的副作用。两名患者出现仰卧位收缩期高血压,用小剂量美托洛尔进行了治疗。

相似文献

1
Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.米多君。治疗特发性直立性低血压和夏伊-德雷格综合征的一种新药。
Mayo Clin Proc. 1981 Jul;56(7):429-33.
2
Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy-Drager syndrome).扎莫特罗治疗多系统萎缩(夏伊-德雷格综合征)相关的体位性低血压
Q J Med. 1990 Feb;74(274):209-13.
3
Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome.普瑞特罗对夏伊-德雷格综合征体位性低血压的影响。
Br Med J (Clin Res Ed). 1984 Mar 17;288(6420):817-8. doi: 10.1136/bmj.288.6420.817.
4
Pharmacodynamics of midodrine, an antihypotensive agent.
Clin Pharmacol Ther. 1986 May;39(5):586-91. doi: 10.1038/clpt.1986.101.
5
Midodrine in neurogenic orthostatic hypotension. A new treatment.米多君用于神经源性直立性低血压。一种新的治疗方法。
Int Angiol. 1993 Jun;12(2):125-31.
6
[Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].口服L-苏型-3,4-二羟基苯丝氨酸对Shy-Drager综合征患者直立性低血压的临床疗效
Rinsho Shinkeigaku. 1987 Mar;27(3):300-4.
7
[Acetylsalicylic acid and indomethacin in the treatment of idiopathic orthostatic hypotension and Shy-Drager's syndrome].
Ugeskr Laeger. 1985 Apr 1;147(14):1196-8.
8
Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).使用外周α-肾上腺素能激动剂(米多君)治疗自主神经功能衰竭所致的体位性低血压。
Neurology. 1988 Jun;38(6):951-6. doi: 10.1212/wnl.38.6.951.
9
Pyridostigmine treatment trial in neurogenic orthostatic hypotension.神经源性直立性低血压的吡啶斯的明治疗试验
Arch Neurol. 2006 Apr;63(4):513-8. doi: 10.1001/archneur.63.4.noc50340. Epub 2006 Feb 13.
10
Indomethacin and propranolol combined treatment for Shy-Drager syndrome.吲哚美辛与普萘洛尔联合治疗Shy-Drager综合征
J Neurol Neurosurg Psychiatry. 1982 May;45(5):472-3. doi: 10.1136/jnnp.45.5.472.

引用本文的文献

1
Midodrine use in critically ill patients: a narrative review.去氧肾上腺素在危重症患者中的应用:一项叙述性综述。
Crit Care Resusc. 2023 Oct 16;24(4):298-308. doi: 10.51893/2022.4.R. eCollection 2022 Dec 5.
2
Oral Midodrine as an Adjunct in Rapid Weaning of Intravenous Vasopressor Support in Spinal Cord Injury.口服米多君作为脊髓损伤患者快速停用静脉血管升压药支持治疗的辅助用药
Asian J Neurosurg. 2023 Jun 16;18(2):306-311. doi: 10.1055/s-0043-1769755. eCollection 2023 Jun.
3
The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson's Disease: What We Know and Where to Go.
帕金森病中心血管自主神经功能障碍的发病机制与治疗:我们所了解的及未来方向
Aging Dis. 2021 Oct 1;12(7):1675-1692. doi: 10.14336/AD.2021.0214. eCollection 2021 Oct.
4
Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.神经原性直立性低血压的临床试验:终点、陷阱和挑战的综合评价。
Semin Neurol. 2020 Oct;40(5):523-539. doi: 10.1055/s-0040-1713846. Epub 2020 Sep 9.
5
Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.盐酸米多君对症状性直立性低血压的临床疗效:一项4期、双盲、安慰剂对照、随机倾斜试验研究
Clin Auton Res. 2016 Aug;26(4):269-77. doi: 10.1007/s10286-016-0363-9. Epub 2016 Jul 2.
6
Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.肾移植前使用米多君:肾移植术后并发症新发现的风险标志物。
Transplantation. 2016 May;100(5):1086-93. doi: 10.1097/TP.0000000000001113.
7
Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure.麦角胺咖啡因联合治疗可改善自主神经衰竭患者坐位血压和晕厥前症状。
Front Physiol. 2014 Jul 24;5:270. doi: 10.3389/fphys.2014.00270. eCollection 2014.
8
Management of neurogenic orthostatic hypotension in patients with autonomic failure.自主神经衰竭患者神经源性直立性低血压的管理。
Drugs. 2013 Aug;73(12):1267-79. doi: 10.1007/s40265-013-0097-0.
9
Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.血浆多巴胺β-羟化酶活性的人类遗传学:在精神病学和神经病学研究中的应用
Psychopharmacology (Berl). 2004 Aug;174(4):463-76. doi: 10.1007/s00213-004-1840-8. Epub 2004 Apr 16.
10
Failure of erythropoietin treatment in a case with primary autonomic failure.一例原发性自主神经功能衰竭患者促红细胞生成素治疗失败
Clin Auton Res. 1997 Dec;7(6):333-6. doi: 10.1007/BF02267727.